Concurrent EGFR and KRAS Mutations in Non-Small Cell Lung Cancer: Challenging the Paradigm of Linear Targeted Therapy. J Curr Biomed Rep 2025, 6 (2), 45-46. https://doi.org/10.61882/jcbior.6.2.299.